“Comparative Efficacy of Anastrozole, Letrozole, and Fulvestrant As Endocrine Partners Combined With CDK4 6 Inhibitors in Patients With HR+ HER2– Metastatic Breast Cancer: A Real-World Evidence from the Stavropol Regional Clinical Oncology Center”. Voprosy Onkologii, vol. 71, no. 6, Dec. 2025, p. OF-2376, https://doi.org/10.37469/0507-3758-2025-71-6-OF-2376.